Envision Healthcare Holdings Inc : Price acceleration in sight!
Entry price | Target | Stop-loss | Potential |
---|
$34.61 |
$0 |
$33.4 |
-100% |
---|
Envision Healthcare could resume its upward trend after recent losses.
According to Surperformance© ratings, the group has strong fundamentals, both in terms of business predictability and valuation. In addition, analysts have been revising upward its earnings estimates and nowadays expect a profit of $0.88 per share for the current year. Debts reductions may imply lower leverage levels in a three-year horizon.
Technically, the ascending triangle pattern suggest prices rises. In the short term, a sharp decline led the share close to the USD 33.9 support, a key level that may now push prices toward higher levels as it also matches with the lower bound of the bullish configuration. Therefore, if a technical rebound takes place the target could be fixed near the USD 36.6 weekly resistance.
Consequently, long positions should be opened at current prices, looking then for the USD 36.6 level. A stop-loss order may be set below the USD 33.9 support.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.